This vaccine utilizes two irradiated allogeneic pancreatic tumor cell lines transfected with the GM-CSF gene to induce an adaptive immune response like attenuated viral/bacterial vaccines while simultaneously stimulating the immune system, ultimately resulting in host-derived targeting of the tumor. This evidence concerns the gene CSF2 and neoplasm.